MindBio Therapeutics Press Lunch

Microdosing with LSD: Phase 1 Clinical Trial Results. Phase 2 Plan

Details

Press Lounge

Track Format: Press Lunch


Date:	11/03/2022
Start Time:	3:00 pm
End Time:	16:30

Justin Hanka

Co-Founder & Director, MindBio Therapeutics

Justin Hanka (Co-Founder & Director) is an investment banker with expertise in M&A and capital markets transactions in Australia, Europe and North America.

Get Recordings Now!

Easily access the recordings for your favorite Wonderland sessions, allowing you to revisit the discussions and insights shared by our visionary speakers.